Cargando…

Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasia

BACKGROUND: Preclinical testing of potential therapies for Duchenne muscular dystrophy (DMD) is conducted predominantly of the mdx mouse. But lack of a detailed quantitative description of the pathology of this animal limits our ability to evaluate the effectiveness of putative therapies or their re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duddy, William, Duguez, Stephanie, Johnston, Helen, Cohen, Tatiana V, Phadke, Aditi, Gordish-Dressman, Heather, Nagaraju, Kanneboyina, Gnocchi, Viola, Low, SiewHui, Partridge, Terence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434871/ https://www.ncbi.nlm.nih.gov/pubmed/25987977 http://dx.doi.org/10.1186/s13395-015-0041-y

Ejemplares similares

The Proton Pump Inhibitor Lansoprazole Improves the Skeletal Phenotype in Dystrophin Deficient mdx Mice
por: Sali, Arpana, et al.
Publicado: (2013)

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
por: Tatem, Kathleen S., et al.
Publicado: (2014)

Glucocorticoid-Treated Mice Are an Inappropriate Positive Control for Long-Term Preclinical Studies in the mdx Mouse
por: Sali, Arpana, et al.
Publicado: (2012)

Biomarker-focused multi-drug combination therapy and repurposing trial in mdx mice
por: Ziemba, Michael, et al.
Publicado: (2021)

Atmospheric Oxygen Tension Slows Myoblast Proliferation via Mitochondrial Activation
por: Duguez, Stephanie, et al.
Publicado: (2012)

Non-Invasive MRI and Spectroscopy of mdx Mice Reveal Temporal Changes in Dystrophic Muscle Imaging and in Energy Deficits
por: Heier, Christopher R., et al.
Publicado: (2014)

Correction: Functional and Molecular Effects of Arginine Butyrate and Prednisone on Muscle and Heart in the Dystrophin Deficient mdx mice
por: Guerron, Alfredo D., et al.
Publicado: (2010)

Correction: Functional and Molecular Effects of Arginine Butyrate and Prednisone on Muscle and Heart in the Dystrophin Deficient mdx mice
por: Guerron, Alfredo D., et al.
Publicado: (2010)

Correction: Functional and Molecular Effects of Arginine Butyrate and Prednisone on Muscle and Heart in the Dystrophin Deficient mdx mice
por: Guerron, Alfredo D., et al.
Publicado: (2010)

Functional and Molecular Effects of Arginine Butyrate and Prednisone on Muscle and Heart in the mdx Mouse Model of Duchenne Muscular Dystrophy
por: Guerron, Alfredo D., et al.
Publicado: (2010)

Is labral hypotrophy correlated with increased acetabular depth?
por: Toft, Felix, et al.
Publicado: (2015)

Metabolic remodeling agents show beneficial effects in the dystrophin-deficient mdx mouse model
por: Jahnke, Vanessa E, et al.
Publicado: (2012)

Myofiber branching rather than myofiber hyperplasia contributes to muscle hypertrophy in mdx mice
por: Faber, Rachel M, et al.
Publicado: (2014)

“Of Mice and Measures”: A Project to Improve How We Advance Duchenne Muscular Dystrophy Therapies to the Clinic: First Workshop Report: Examining current findings and opportunities around the emerging D2.B10-Dmd(mdx)/J (D2/mdx) model in context of the classic C57BL/10ScSn-Dmd(mdx)/J (Bl10/mdx)
por: Gordish-Dressman, Heather, et al.
Publicado: (2018)

Effects of Dantrolene Therapy on Disease Phenotype in Dystrophin Deficient mdx Mice
por: Quinn, James L, et al.
Publicado: (2013)

Role of non-immune mechanisms of muscle damage in idiopathic inflammatory myopathies
por: Coley, William, et al.
Publicado: (2012)

Effect of the IL-1 Receptor Antagonist Kineret(®) on Disease Phenotype in mdx Mice
por: Benny Klimek, Margaret E., et al.
Publicado: (2016)

Idiopathic inflammatory myopathies: pathogenic mechanisms of muscle weakness
por: Rayavarapu, Sree, et al.
Publicado: (2013)

Characterization of Dysferlin Deficient SJL/J Mice to Assess Preclinical Drug Efficacy: Fasudil Exacerbates Muscle Disease Phenotype
por: Rayavarapu, Sree, et al.
Publicado: (2010)

Myofiber-specific TEAD1 overexpression drives satellite cell hyperplasia and counters pathological effects of dystrophin deficiency
por: Southard, Sheryl, et al.
Publicado: (2016)

Greater Colo-Rectal Activation Phenotype in Exercised mdx Mice
por: Nearing, Marie, et al.
Publicado: (2018)

IL-6 signaling blockade increases inflammation but does not affect muscle function in the mdx mouse
por: Kostek, Matthew C, et al.
Publicado: (2012)

Testicular volume and fertility potential in men operated due to varicocele and testicular hypotrophy in adolescence
por: Bryniarski, Piotr, et al.
Publicado: (2013)

Late-presenting right congenital diaphragmatic hernia with severe hypotrophy of the right lobe of the liver
por: De Marco, E.A., et al.
Publicado: (2015)

Non-invasive Optical Imaging of Muscle Pathology in mdx Mice Using Cathepsin Caged Near-Infrared Imaging
por: Baudy, Andreas R., et al.
Publicado: (2010)

Tendon regeneration and muscle hypotrophy after isolated Gracilis tendon harvesting - a pilot study
por: Flies, Anne, et al.
Publicado: (2020)

Evaluation of Skeletal and Cardiac Muscle Function after Chronic Administration of Thymosin β-4 in the Dystrophin Deficient Mouse
por: Spurney, Christopher F., et al.
Publicado: (2010)

Targeted Inactivation of the Androgen Receptor Gene in Murine Proximal Epididymis Causes Epithelial Hypotrophy and Obstructive Azoospermia
por: Krutskikh, Anton, et al.
Publicado: (2011)

Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy
por: Casciola-Rosen, Livia, et al.
Publicado: (2005)

Discovery of potential urine-accessible metabolite biomarkers associated with muscle disease and corticosteroid response in the mdx mouse model for Duchenne
por: Thangarajh, Mathula, et al.
Publicado: (2019)

Mandibular Vertical Growth Deficiency After Botulinum-Induced Hypotrophy of Masticatory Closing Muscles in Juvenile Nonhuman Primates
por: Kim, Hak-Jin, et al.
Publicado: (2019)

Long-Term Efficacy of Systemic Multiexon Skipping Targeting Dystrophin Exons 45–55 With a Cocktail of Vivo-Morpholinos in Mdx52 Mice
por: Echigoya, Yusuke, et al.
Publicado: (2015)

Understanding Neuromuscular Health and Disease: Advances in Genetics, Omics, and Molecular Function
por: Duddy, William J., et al.
Publicado: (2021)

Omigapil Treatment Decreases Fibrosis and Improves Respiratory Rate in dy(2J) Mouse Model of Congenital Muscular Dystrophy
por: Yu, Qing, et al.
Publicado: (2013)

Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomes
por: Hoffman, Eric P., et al.
Publicado: (2018)

The use of urinary and kidney SILAM proteomics to monitor kidney response to high dose morpholino oligonucleotides in the mdx mouse
por: Zhang, Aiping, et al.
Publicado: (2015)

Personalized Medicine and Molecular Interaction Networks in Amyotrophic Lateral Sclerosis (ALS): Current Knowledge
por: Morgan, Stephen, et al.
Publicado: (2018)

Muscle Gene Sets: a versatile methodological aid to functional genomics in the neuromuscular field
por: Malatras, Apostolos, et al.
Publicado: (2019)

Genome-Wide Gene-Set Analysis Approaches in Amyotrophic Lateral Sclerosis
por: Vasilopoulou, Christina, et al.
Publicado: (2022)

The Cellular and Molecular Signature of ALS in Muscle
por: Anakor, Ekene, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e8aetm99q9frkqssvesl4pflbf